Atara Biotherapeutics, Inc.ATRANASDAQ
Loading
Cost of Revenue Over TimeContracting
Percentile Rank85
5Y CAGR-38.7%
Studio
Year-over-Year Change

Direct costs attributable to producing goods sold

5Y CAGR
-38.7%/yr
Long-term compound
Percentile
P85
Within normal range
vs 5Y Ago
0.1x
Contraction
Streak
3 yr
Consecutive growthContracting
PeriodValueYoY Change
TTM$21.21M+1.0%
2024$21.01M+136.4%
2023$8.89M-
2022$0.00-100.0%
2021$282.00M+15.3%
2020$244.65M-
2019$0.00-100.0%
2018$3.78M+295.5%
2017$956000.00+149.6%
2016$383000.00-